Table of Contents
Introduction: Conflict of Interest and the Politics of Biomedicine
Part 1. Knowledge and Expertise
1. A Genealogy of Conflict of Interest
2. "Conflict of Interest" or Simply "Interest"? Shifting Values in Translational Medicine
3. Managing Conflicts of Interest at the European Medicines Agency: Success or Weakness of the Soft Law Tools?
4. From the Management of Conflicts of Interest to the Transformation of Medical Experts’ Profiles. The Members of the Transparency Committee in France (2000–2020)
Part 2. Physicians and the Framing of Prescription Practices
5. Conflicts of Interest in Medical Practice: Causes and Cures
6. In Whose Best Interest? Framing Pharmacists’ and Physicians’ (Conflicts of) Interest in the French Market for Generic Drugs
7. The Politics of Industrial Transparency. Constructing a Database on the Pharmaceutical Funding of the Health Sector
8. Scientific Marketing and Conflict of Interest: Lessons From the Hormone Replacement Therapies (HRT) Crisis
Part 3. Mobilizations and Controversies
9. "This Corporation Has ‘Anesthetized’ the Actors in the Drug Chain". Influence Peddling and the Normality of Conflicts of Interest in the Mediator® Scandal
10. For Science, by Science. The Emergence and Circulation of Conflict of Interest as a Protest Repertoire to Fight Against Pesticides
11. Conflict of interest, Capture, Production of Ignorance, and Hegemony: Conceptualizing the Influence of Corporate Interests on Public Health
Postface: Conflict of Interest, Industry Hegemony and Key Opinion Leader Management